Know Cancer

or
forgot password

Benefits Study of a Respiratory Gating Protocol for Positron Emission Tomography: Application on the Lungs


N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Cancer, Non Small Cell Lung Cancer

Thank you

Trial Information

Benefits Study of a Respiratory Gating Protocol for Positron Emission Tomography: Application on the Lungs


Inclusion Criteria:



- patient has one or more lung lesion(s) less than 35 mm visible on a CT image

- age : over 18 years

- patients gave their written informed consent

Exclusion Criteria:

- pregnancy

- patient has at least one lesion more than 35 mm in its great axis

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic

Outcome Measure:

Lesion SUVmax

Outcome Description:

For each CT nodule, observer has to report the corresponding (maximum Standardized Uptake Value)SUVmax on ungated and CT-based images (even if there is no obvious uptake)

Outcome Time Frame:

Day 1

Safety Issue:

No

Principal Investigator

Marc-Etienne MEYER, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

CHU Amiens

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

AOL09-PR-MEYER

NCT ID:

NCT01812031

Start Date:

August 2009

Completion Date:

February 2015

Related Keywords:

  • Lung Cancer
  • Non Small Cell Lung Cancer
  • PET/CT
  • 18F-fluoro-2-deoxyglucose
  • lung neoplasms
  • respiratory motion
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location